We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLI icon
1151
Houlihan Lokey
HLI
$8.63B
-7,459
Closed -$1.3M
HLNE icon
1152
Hamilton Lane
HLNE
$5.69B
-14,055
Closed -$2.08M
HLT icon
1153
Hilton Worldwide
HLT
$72.6B
-2,450
Closed -$606K
HOMB icon
1154
Home BancShares
HOMB
$6.23B
-35,408
Closed -$1M
HPQ icon
1155
HP
HPQ
$26.8B
-44,083
Closed -$1.44M
HRI icon
1156
Herc Holdings
HRI
$5.63B
-8,224
Closed -$1.56M
HTH icon
1157
Hilltop Holdings
HTH
$2.25B
-17,426
Closed -$499K
HTHT icon
1158
Huazhu Hotels Group
HTHT
$12.7B
-15,439
Closed -$510K
IART icon
1159
Integra LifeSciences
IART
$1.35B
-55,840
Closed -$1.27M
ICE icon
1160
Intercontinental Exchange
ICE
$85B
-70,023
Closed -$10.4M
IDXX icon
1161
Idexx Laboratories
IDXX
$45B
-2,939
Closed -$1.22M
IIPR icon
1162
Innovative Industrial Properties
IIPR
$1.67B
-3,243
Closed -$216K
INDV icon
1163
Indivior Pharmaceuticals
INDV
$4.57B
-25,391
Closed -$325K
INN
1164
Summit Hotel Properties
INN
$655M
-23,417
Closed -$160K
INSE icon
1165
Inspired Entertainment
INSE
$163M
-10,474
Closed -$94.8K
INSW icon
1166
International Seaways
INSW
$4.58B
-41,051
Closed -$1.48M
INTU icon
1167
Intuit
INTU
$91.6B
-894
Closed -$562K
IONS icon
1168
Ionis Pharmaceuticals
IONS
$9.39B
-15,681
Closed -$548K
IR icon
1169
Ingersoll Rand
IR
$32.9B
-31,152
Closed -$2.82M
ITW icon
1170
Illinois Tool Works
ITW
$83.3B
-18,165
Closed -$4.61M
JBLU icon
1171
JetBlue
JBLU
$2.18B
-71,714
Closed -$564K
KAI icon
1172
Kadant
KAI
$3.94B
-1,048
Closed -$362K
OPLN
1173
Openlane
OPLN
$4.34B
-27,824
Closed -$552K
KE
1174
Kimball Electronics
KE
$606M
-16,870
Closed -$316K
KEYS icon
1175
Keysight
KEYS
$60.6B
-7,982
Closed -$1.28M

Similar funds

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.